Search results for "Injection"

showing 10 items of 920 documents

A Multi-Variate Predictability Framework to Assess Invasive Cardiac Activity and Interactions during Atrial Fibrillation

2017

Objective: This study introduces a predictability framework based on the concept of Granger causality (GC), in order to analyze the activity and interactions between different intracardiac sites during atrial fibrillation (AF). Methods: GC-based interactions were studied using a three-electrode analysis scheme with multi-variate autoregressive models of the involved preprocessed intracardiac signals. The method was evaluated in different scenarios covering simulations of complex atrial activity as well as endocardial signals acquired from patients. Results: The results illustrate the ability of the method to determine atrial rhythm complexity and to track and map propagation during AF. Conc…

medicine.medical_specialtyComputer science0206 medical engineeringAtrial fibrillation (AF)Biomedical EngineeringCardiac activity02 engineering and technology030204 cardiovascular system & hematologyIntracardiac injectionmulti-variate autoregressive (MVAR) modeling03 medical and health sciences0302 clinical medicineHeart Conduction SystemInternal medicineAtrial Fibrillationmultielectrode cathetermedicineHumansComputer SimulationPredictabilityModels Statisticalbusiness.industryBody Surface Potential MappingModels CardiovascularPattern recognitionAtrial fibrillationmedicine.disease020601 biomedical engineeringRandom variateAutoregressive modelData Interpretation Statisticalbipolar electrograms (EGMs)Multivariate AnalysisSettore ING-INF/06 - Bioingegneria Elettronica E InformaticaCardiologyGranger causality (GC)Artificial intelligencebusiness
researchProduct

Osmolality of various viscoelastic substances: comparative study.

2000

Abstract Purpose To determine the osmolality of various viscoelastic substances. Setting Department of Ophthalmology, Johannes Gutenberg-University, Mainz, and Institute for Medical Device Testing, Memmingen, Germany. Methods The analysis was carried out according to the European Pharmacopoeia by means of a calibrated osmometer using the freezing-point depression method. Each syringe was analyzed as a duplicate analysis. Results Mean osmolalities (mOsmol/kg) of the sodium hyaluronate viscoelastic substances were Allervisc® 299; Allervisc® Plus 307; Amvisc® Plus 335; AMO Vitrax® 284; Biolon® 279; Dispasan® 311; Dispasan® Plus 314; Healon® 295; Healon GV® 312; Healon®5 322; HYA-Ophtal® 376; M…

medicine.medical_specialtyCorneal endotheliumAnterior ChamberSodium hyaluronateCataract ExtractionMethylcelluloseOsmolar ConcentrationInjectionsCorneachemistry.chemical_compoundHypromellose DerivativesOsmometerOphthalmologymedicineHumansIn patientProtease InhibitorsHyaluronic AcidViscoelastic SubstancesOsmotic concentrationbusiness.industryOsmolar ConcentrationReproducibility of ResultsHypromellose DerivativesSensory SystemsOphthalmologychemistrySurgerybusinessJournal of cataract and refractive surgery
researchProduct

Therapeutic use of hyaluronic acid fillers in the treatment of corticosteroid-induced skin and subcutaneous atrophy

2016

Corticosteroid injection–related tissue atrophy might cause permanent skin and soft tissue deformities1 due to several factors, most importantly fibroblast inhibition and decreased Type I collagen synthesis. Correction of these deformities is challenging and is mostly based on volume replacement with lipofilling or other methods. Clinical observations and research have shown that injection of stabilized hyaluronic acid (HA) induces collagen synthesis, partially restoring dermal matrix components, and eventually producing a permanent effect.2–5 Based on these data, we hypothesize that HA injections might successfully treat atrophic tissue changes caused by corticosteroid injection. We descri…

medicine.medical_specialtyDermal FillerEstheticsLipodystrophymedicine.drug_classInjections SubcutaneousSettore MED/19 - Chirurgia PlasticaBiocompatible MaterialsDermatologyCosmetic TechniquesAdrenal Cortex HormoneInjections SubcutaneouDermal Fillers030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineAtrophyIn vivoAdrenal Cortex HormonesDermal FillersHyaluronic acidmedicineHumansButtocksHyaluronic AcidBiocompatible MaterialCosmetic Techniquebusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseDermatologymedicine.anatomical_structureCosmetic Techniqueschemistry030220 oncology & carcinogenesisCorticosteroidButtocksSurgeryFemaleLipodystrophyAtrophybusinessEstheticHuman
researchProduct

Prolonged-release buprenorphine formulations: Perspectives for clinical practice

2020

International audience; Buprenorphine and methadone are the two main opioid agonist treatments approved for opioid use disorder. Buprenorphine is a partial agonist of the mu opioid receptors, which has been merely available through sublingual form until now. In practice, the use of buprenorphine is smoother than that of methadone, and it induces reduced risks of overdose. However, sublingual buprenorphine also exposes to risks (e.g., withdrawal, misuse) and constraints (e.g., daily intake). Three new galenic formulations of prolonged-release buprenorphine (PRB) are being commercialized and should allow some improvements in patients' comfort and safety. This narrative review aims to describe…

medicine.medical_specialtyDoseNarcotic Antagonists[SDV.MHEP.PSM] Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthReceptors Opioid mu030226 pharmacology & pharmacyPartial agonistOpioid dependenceDependance aux opioides03 medical and health sciencesSubcutaneous injection0302 clinical medicineProlonged releasemedicineHumansProlonged-releasePharmacology (medical)OpiacésAction prolongeebusiness.industryOpioid use disorderOpioid-Related Disordersmedicine.disease3. Good healthBuprenorphineAnalgesics OpioidOpiatesOpioid[SDV.MHEP.PSM]Life Sciences [q-bio]/Human health and pathology/Psychiatrics and mental healthEmergency medicinebusinessSubstitutionMethadoneBuprenorphinemedicine.drugMethadone
researchProduct

Ultrasound-guided musculoskeletal interventional procedures around the shoulder

2021

Ultrasound is a fast, accessible, reliable, and radiation-free imaging modality routinely used to assess the soft tissues around the shoulder. It enables to identify a wide range of pathological conditions. Furthermore, most ultrasound-guided musculoskeletal interventional procedures around the shoulder produce better results in terms of accuracy and clinical efficacy than those performed in a blinded fashion. Indeed, intra-articular and peri-articular interventional procedures can be easily performed under continuous ultrasound monitoring to ensure the correct position of the needle and to deliver the medication to a specific target. Several technical approaches and medications can be used…

medicine.medical_specialtyDry needlingRadiological and Ultrasound TechnologyBursitismedicine.diagnostic_testbusiness.industryshoulderultrasoundUltrasoundInterventional radiologyOsteoarthritisSuprascapular nervemedicine.diseaseCapsulitismedicine.anatomical_structureinterventional radiologymedicineMedicineRadiology Nuclear Medicine and imagingRotator cuffRadiologybusinessinjectionsJournal of Ultrasonography
researchProduct

Complications of botulinum toxin and fillers: A narrative review

2019

Background Cosmetic surgery and esthetic procedures have become a billion dollar industry owing to the ever-growing demand of the population to stay young. The injectable treatments including fillers and botulinum toxin have become highly popular because of their quick, predictable and lasting results in the management of facial wrinkles and rejuvenation. Although these treatment modalities are relatively safe, they are associated with certain side effects. Aims In this review, we will focus on the complications of fillers and botulinum toxin. Patients/methods The literature research considered published journal articles (clinical trials or scientific reviews). Studies were identified by se…

medicine.medical_specialtyEcchymosisPopulationMEDLINEFacial MusclesCosmetic TechniquesDermatologyPain ProceduralInjections030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineDermal FillersHumansMedicineBotulinum Toxins Type AeducationIntensive care medicineAdverse effecteducation.field_of_studybusiness.industryBotulinum toxinInjection Site ReactionClinical trialFacial AsymmetryNeuromuscular Agents030220 oncology & carcinogenesisBrow ptosisNarrative reviewEyebrowsmedicine.symptombusinessmedicine.drugJournal of Cosmetic Dermatology
researchProduct

Comment on: Comparative characteristics of older people with type 1 diabetes treated with continuous subcutaneous insulin infusion or insulin injecti…

2020

medicine.medical_specialtyEndocrinology Diabetes and MetabolismMEDLINEGermanEndocrinologyInsulin Infusion SystemsInternal medicineInternal MedicineMedicineHumansHypoglycemic AgentsInsulinRegistriesInsulin injectionAgedAged 80 and overType 1 diabetesbusiness.industrymedicine.diseaselanguage.human_languageSubcutaneous insulinDiabetes Mellitus Type 1AustrialanguagebusinessOlder peopleDiabetic medicine : a journal of the British Diabetic Association
researchProduct

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

2011

Abstract The history of ascorbic acid (AA) and cancer has been marked with controversy. Clinical studies evaluating AA in cancer outcome continue to the present day. However, the wealth of data suggesting that AA may be highly beneficial in addressing cancer-associated inflammation, particularly progression to systemic inflammatory response syndrome (SIRS) and multi organ failure (MOF), has been largely overlooked. Patients with advanced cancer are generally deficient in AA. Once these patients develop septic symptoms, a further decrease in ascorbic acid levels occurs. Given the known role of ascorbate in: a) maintaining endothelial and suppression of inflammatory markers; b) protection fro…

medicine.medical_specialtyEndotheliummedicine.medical_treatmentlcsh:MedicineInflammationReviewAscorbic AcidMicrobiologyGastroenterologyGeneral Biochemistry Genetics and Molecular BiologySepsisNeoplasmsSepsisInternal medicinemedicineHumansEndotheliumAscorbic Acid DeficiencyCancerImmunology and Infectious DiseaseMedicine(all)Biochemistry Genetics and Molecular Biology(all)business.industrylcsh:RImmunityCancerGeneral Medicinemedicine.diseaseAscorbic acidSystemic inflammatory response syndromemedicine.anatomical_structureOncologyInjections IntravenousImmunologyAscorbic Acid DeficiencyIntravenous ascorbic acidmedicine.symptombusinessAdjuvantJournal of Translational Medicine
researchProduct

The safety of intravenous fluorescein for confocal laser endomicroscopy in the gastrointestinal tract

2010

Aliment Pharmacol Ther 31, 548–552 Summary Background  Confocal laser endomicroscopy (CLE) is rapidly emerging as a valuable tool for gastrointestinal endoscopic imaging. Fluorescent contrast agents are used to optimize imaging with CLE, and intravenous fluorescein is the most widely used contrast agent. Fluorescein is FDA-cleared for diagnostic angiography of the retina. For these indications, the safety profile of fluorescein has been well-documented; however, to date, fluorescein is not cleared for use with CLE. Aims  To estimate the rate of serious and total adverse events attributable to intravenous fluorescein when used for gastrointestinal CLE. Methods  We performed a cross sectional…

medicine.medical_specialtyErythemaNauseaGastrointestinal DiseasesVomitingContrast MediaPainEndoscopy Gastrointestinalchemistry.chemical_compoundmedicineHumansPharmacology (medical)FluoresceinAdverse effectGastrointestinal tractMicroscopy ConfocalHepatologymedicine.diagnostic_testbusiness.industryUnited States Food and Drug AdministrationStomachfungiGastroenterologyNauseaExanthemaUnited StatesSurgeryEndoscopymedicine.anatomical_structureCross-Sectional StudieschemistryAnesthesiaInjections IntravenousVomitingFluoresceinmedicine.symptomHypotensionbusinessAlimentary pharmacology & therapeutics
researchProduct

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE

1964

medicine.medical_specialtyGlucose tolerance testmedicine.diagnostic_testDuodenumbusiness.industryResearchGeneral MedicineGlucose Tolerance TestGastroenterologyIntestinal absorptionInjectionsJejunumDogsGlucoseJejunummedicine.anatomical_structureIntestinal AbsorptionInternal medicineInjections IntravenousmedicineDuodenumAnimalsOral glucose tolerancebusinessThe Lancet
researchProduct